Fish oil supplementation in pregnancy to reduce allergies in early childhood

Phase 4

Completed

• Conditions: Allergic Disease; Inflammatory and Immune System - Allergies; Alternative and Complementary Medicine - Other alternative and complementary medicine

• Registration Number: ACTRN12610000735055
• Lead Sponsor: Women's and Children's Health Research Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-09-03
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 616

Inclusion Criteria

Child to have a family history of medically diagnosed allergic disease (eczema, asthma, allergic rhinitis):
singleton pregnancy less than 18-21 weeks gestation with no known fetal abnormality: mothers not to have had documented history of alcohol or drug abuse: no participation in other clinical trials with fatty acid intervention.

Exclusion Criteria

Maternal bleeding disorders where DHA tuna oil is contraindicated

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Medical diagnosis (from a clinical examination) of allergic disease (eczema, asthma, allergic rhinitis or food allergy) with sensitisation (determined by a positive skin prick test to food allergens or aeroallergens) in the child[At 1 and 3 years of age]

Secondary Outcome Measures

Name	Time	Method
Medical diagnosis (from a clinical examination) of allergic disease (eczema, asthma, allergic rhinitis or food allergy) without sensitisation in the child[At 1 and 3 years of age];Any Sensitisation (determined by a positive skin prick test to food allergens or aeroallergens) in the child[At 1 and 3 years of age]